Market Overview

Lightning Round: Jim Cramer Weighs In On Bristol-Myers Squibb, Mazor Robotics And More

Share:
Related BMY
FDA Decisions In November: The Month In Review
A Lazarus Act For This Pharma ETF
The Vetr community has downgraded $BMY to 3-Stars (Vetr)
Related
Jim Cramer Gives His Opinion On Mazor Robotics And Arista Networks
30 Stocks Moving In Monday's Mid-Day Session

Jim Cramer spoke on CNBC's "Mad Money Lightning Round" about Bristol-Myers Squibb Co (NYSE: BMY). He said the stock came back and made a new high despite losing a bunch head-to-heads against Keytruda. He likes the stock.

Cramer advised his viewer to hold Mazor Robotics Ltd - ADR (NASDAQ: MZOR) because it's going to be the next Intuitive Surgical, Inc. (NASDAQ: ISRG). He added that problems the company had with Israeli government have passed.

Himax Technologies, Inc. (ADR) (NASDAQ: HIMX) is a speculative stock, thinks Cramer.

Iridium Communications Inc (NASDAQ: IRDM) had a good comeback, but Cramer doesn't see anything that should have driven the stock up so much.

Cramer likes Zagg Inc (NASDAQ: ZAGG) and he thinks there's a lot to the company. He also likes devices that give us more battery life.

Cramer also likes McCormick & Company (NYSE: MKC). He likes its recent acquisition.

Posted-In: mad money Lightning RoundCNBC Jim Cramer Media

 

Related Articles (HIMX + BMY)

View Comments and Join the Discussion!

Partner Center